financetom
Business
financetom
/
Business
/
Mexican lender Banorte cuts 2025 profit guidance after digital bank sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mexican lender Banorte cuts 2025 profit guidance after digital bank sale
Nov 4, 2025 4:49 PM

MEXICO CITY, Nov 4 (Reuters) -

Mexican lender Banorte cut its 2025 net income

outlook as it reported its third-quarter results on Tuesday, in

which it posted a 9% profit dip partly because of the divestment

of its digital bank Bineo, as well as a riskier loan book.

Banorte, which owns one of the country's largest banks and

pension funds, lowered its 2025 net income guidance to 58.2-59.2

billion pesos ($3.17-$3.22 billion) from an earlier level of

59.6-62.1 billion pesos and revised its return on equity to

22%-23% from 21.5%-23%, citing the impairment of Bineo.

Banorte agreed to sell its digital bank unit Bineo to

financial technology firm Klar in September, as part of a larger

overhaul of its digital strategy.

The group recorded "an initial impairment loss" of 1.31

billion pesos from Bineo and de-consolidated the unit from its

results. It also reported a new higher-risk Stage 3 commercial

loan, prompting it to raise its provisions.

The lender also widened its loan growth forecast to 6%-11%

from 8%-11%, citing government loans.

However, it edged up its net interest margin (NIM), a key

profitability metric for banks, to 6.2%-6.5% from a prior

forecast of 6.1%-6.4%.

"We see Banorte's results as weak," analysts at Santander

said. "We continue to note downside risk to consensus estimates

in 2026 based on weaker-than-expected growth in 2025."

RISKIER LOANS

Banorte's net profit of 13.01 billion pesos ($710 million)

fell short of an LSEG-compiled estimate of 14.44 billion pesos,

while total revenue of 40.86 billion pesos beat a forecast of

39.67 billion pesos.

Net interest income, the difference between what banks earn

on loans and dole out in deposits, grew 2% year-over-year

supported by a larger loan book, higher loan origination, a

consumer-focused portfolio mix, and consistent funding cost

optimization.

Total provisions rose 57% in the quarter compared to a year

earlier, largely due to higher reserves for the commercial loan

that was classified as a higher-risk Stage 3 transaction.

Third-quarter Stage 3 loans reached 16.75 billion pesos, up

from 11.35 billion pesos a year earlier, primarily in the

commercial and mortgage portfolios. Banorte said this was driven

by isolated client cases rather than broader trends.

Return on equity ended September at 20.1%, down from 22.9% a

year earlier.

($1 = 18.3694 Mexican pesos)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fintech firm MCAP's Q3 EPS up 125% to $0.09
Fintech firm MCAP's Q3 EPS up 125% to $0.09
Nov 4, 2025
Overview * MCAP ( MCAP ) Q3 EPS rises 125% YoY to $0.09 per share * Company reports Q3 EBITDA of $3.6 mln, YTD EBITDA $16.3 mln * MCAP ( MCAP ) seeks M&A opportunities to enhance shareholder value Outlook * Company seeks M&A opportunities to enhance long-term shareholder value Result Drivers * INVESTMENT IN CUSTOMER RELATIONSHIPS - MCAP (...
Cancer therapy developer Delcath Q3 revenue misses estimates
Cancer therapy developer Delcath Q3 revenue misses estimates
Nov 4, 2025
Overview * Delcath ( DCTH ) Q3 revenue of $20.6 mln missed analyst expectations * Net income for Q3 was $0.8 mln, down from $1.9 mln last year * Company achieved positive adjusted EBITDA of $5.3 mln in Q3 Outlook * Delcath ( DCTH ) expects 2025 revenue between $83 mln and $85 mln * Company anticipates gross margins of...
Exagen Q3 revenue beats analyst expectations
Exagen Q3 revenue beats analyst expectations
Nov 4, 2025
Overview * Exagen Q3 2025 revenue grows 38% yr/yr, beating analyst expectations * Company reports net loss for Q3 2025 despite revenue growth * Exagen expands AVISE CTD test volume and ASP in Q3 2025 Outlook * Exagen ( XGN ) reiterates 2025 revenue guidance of $65 mln to $70 mln * Company expects positive adjusted EBITDA in Q4 2025...
Portillo's Q3 revenue misses estimates 
Portillo's Q3 revenue misses estimates 
Nov 4, 2025
Overview * Portillo's Q3 revenue rose 1.8% yr/yr but missed analyst expectations * Same-restaurant sales decreased 0.8%, driven by lower transactions * Net income for Q3 decreased by $8 mln yr/yr Outlook * Portillo's expects fiscal 2025 revenue between $730 mln and $733 mln * Company projects fiscal 2025 same-restaurant sales decline of 1% to 1.5% * Portillo's anticipates fiscal...
Copyright 2023-2026 - www.financetom.com All Rights Reserved